US Stem Cell (USRM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2014 | 12-2013 | 09-2013 | 06-2013 | 03-2013 | |
| Sales | 392 | 40 | 32 | 20 | 4 |
| Cost of Goods | 164 | N/A | N/A | N/A | N/A |
| Gross Profit | 228 | 9 | 32 | 20 | 4 |
| Operating Expenses | 1,013 | 682 | 1,099 | 612 | 535 |
| Operating Income | -621 | -641 | -1,067 | -592 | -531 |
| Interest Expense | 306 | 167 | 209 | 709 | 352 |
| Other Income | 1,604 | 81 | 129 | 551 | 365 |
| Pre-tax Income | 677 | -727 | -1,147 | -750 | -519 |
| Net Income Continuous | 677 | -727 | -1,147 | -750 | -519 |
| Net Income | $677 | $-727 | $-1,147 | $-750 | $-519 |
| EPS Basic Total Ops | 2.00 | -1.00 | -5.00 | -3.00 | -3.00 |
| EPS Basic Continuous Ops | 1.69 | -1.58 | -4.66 | -3.44 | -2.80 |
| EPS Diluted Total Ops | 1.00 | -1.00 | -5.00 | -3.00 | -3.00 |
| EPS Diluted Continuous Ops | 1.36 | -1.58 | -4.66 | -3.44 | -2.80 |
| EBITDA(a) | $-620 | $-936 | $-771 | $-592 | $-530 |